Ha! There is a very strong argument to say that efficient cancer registration is the prerequisite evidence based indicator for investment in all the other areas, otherwise governments cannot be shown where the cancers are, what types they are, or which sections of the population and how many people are being (or will be) affected. But since already one person is dying from cancer in low and middle income countries every five seconds, let's not argue about the order... We can definitely agree that cancer advocacy needs to be stepped up at all levels and the argument strongly made that money intelligently spent on prevention and awareness creation will result in a net saving to national economies.
HIFA profile: Mark Lodge is Director of Programme Development at the International Network for Cancer Treatment and Research, Oxford, UK. The INCTR is dedicated to helping to build capacity for cancer treatment and research in countries in which such capacity is presently limited, and thereby to create a foundation on which to build strategies designed to lessen the suffering, limit the number of lives lost, and promote the highest quality of life for children and adults with cancer in these countries, and to increase the quantity and quality of cancer research throughout the world. www.inctr.org mlodge AT canet.org